Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality

被引:411
作者
Schwaber, Mitchell J. [1 ]
Klarfeld-Lidji, Shiri [1 ]
Navon-Venezia, Shiri [1 ]
Schwartz, David [2 ]
Leavitt, Azita [1 ]
Carmeli, Yehuda [1 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Div Epidemol & Prevent Med, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, Tel Aviv, Israel
关键词
D O I
10.1128/AAC.01020-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging nosocomial pathogen. Little is known about its risk factors or mortality. We performed a case-case-control study to assess the risks for CRKP isolation and a retrospective cohort study to assess mortality in three groups of hospitalized adults: (i) patients from whom CRKP was isolated, (ii) patients from whom carbapenem-susceptible Klebsiella spp. (CSKS) were isolated, and (iii) controls from whom no Klebsiella spp. were isolated. After adjustment for length of stay (LOS), the demographics, comorbidities, and exposures of each case group were compared with those of the controls. Significant covariates were incorporated into LOS-adjusted multivariable models. In the mortality study, we evaluated the effect of CRKP on in-hospital death. There were 48 patients with CRKP isolation (21 died [44%]), 56 patients with CSKS isolation (7 died [12.5%]), and 59 controls (I died (2%]). Independent risk factors for CRKP isolation were poor functional status (odds ratio [OR], 15.4; 95% confidence interval [CI], 4.0 to 58.6; P < 0.001); intensive care unit (ICU) stay (OR, 17.4; 95% CI, 1.5 to 201.9; P = 0.02); and receipt of antibiotics (OR, 4.4; 95% CI, 1.0 to 19.2; P = 0.05), particularly fluoroquinolones (OR, 7.2; 95% CI, 1.1 to 49.4; P = 0.04). CRKP was independently associated with death when patients with CRKP were compared with patients with CSKS (OR, 5.4; 95% CI, 1.7 to 17.1; P = 0.005) and with controls (OR, 6.7; 95% CI, 2.4 to 18.8; P < 0.001). After adjustment for the severity of illness, CRKP isolation remained predictive of death, albeit with a lower OR (for the CRKP group versus the CSKS group, OR, 3.9; 95% CI, 1.1 to 13.6; and P = 0.03; for the CRKP group versus the controls, OR, 5.0; 95% CI, 1.7 to 14.8; and P = 0.004). CRKP affects patients with poor functional status, an ICU stay, and antibiotic exposure and is an independent predictor of death.
引用
收藏
页码:1028 / 1033
页数:6
相关论文
共 29 条
[1]   Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae [J].
Ahmad, M ;
Urban, C ;
Mariano, N ;
Bradford, PA ;
Calcagni, E ;
Projan, SJ ;
Bush, K ;
Rahal, JJ .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :352-355
[2]   Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[3]  
[Anonymous], 1998, Modern Epidemiology
[4]   Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital [J].
Ben-Ami, R ;
Schwaber, MJ ;
Navon-Venezia, S ;
Schwartz, D ;
Giladi, M ;
Chmelnitsky, I ;
Leavitt, A ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :925-934
[5]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60
[6]   Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents [J].
Bratu, S ;
Tolaney, P ;
Karumudi, U ;
Quale, J ;
Mooty, M ;
Nichani, S ;
Landman, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :128-132
[7]   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[8]   Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York [J].
Bratu, Simona ;
Brooks, Steven ;
Burney, Sibte ;
Kochar, Sandeep ;
Gupta, Jyoti ;
Landman, David ;
Quale, John .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (07) :972-975
[9]  
Clinical and Laboratory Standards, 2005, PERF STAND ANT SUSC
[10]   Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study [J].
Falagas, Matthew E. ;
Rafailidis, Petros I. ;
Kofteridis, Diamantis ;
Virtzili, Simona ;
Chelvatzoglou, Fotini C. ;
Papaioannou, Vassiliki ;
Maraki, Sofia ;
Samonis, George ;
Michalopoulos, Argyris .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) :1124-1130